Longevity Biosplice files FDA application for knee osteoarthritis drugBy adminJanuary 15, 20260 Biosplice submits NDA for lorecivivint, a potential first-of-its-kind therapy that aims to slow knee osteoarthritis itself. Osteoarthritis shapes how millions…
Probiotics Novel Food application process may be exploited to delay competitorsBy adminSeptember 5, 20250 If unsure whether a product is a Novel Food, an applicant can ask a Member State authority for a ruling.…
